Anna Helbok
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoparticle-Based Drug Delivery 6
-
- Radiopharmaceutical Chemistry and Applications 5
- Medical Imaging Techniques and Applications 1
- Co-authors
- Clemens Decristoforo (14 shared papers)Miloš Petřík (4 shared papers)Hubertus Haas (4 shared papers)Michael Blatzer (3 shared papers)Markus Schrettl (3 shared papers)Cornelia Lass‐Flörl (2 shared papers)Elisabeth von Guggenberg (10 shared papers)Christine Rangger (6 shared papers)
- Journals
- Nuclear Medicine and Biology (3 papers)European Journal of Nuclear Medicine and Molecular Imaging (3 papers)Histochemistry and Cell Biology (2 papers)Nanomedicine Nanotechnology Biology and Medicine (1 paper)Journal of Nuclear Medicine (1 paper)
- Partner nations
- AustriaTürkiyeUnited Kingdom
In The Last Decade
Anna Helbok
17 papers receiving 645 citations
Peers
Comparison fields: 5 of 77
- Radiology, Nuclear Medicine and Imaging 206
- Biomaterials 99
- Infectious Diseases 111
- Molecular Medicine 29
- Epidemiology 161
Countries citing papers authored by Anna Helbok
This map shows the geographic impact of Anna Helbok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Helbok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Helbok more than expected).
Fields of papers citing papers by Anna Helbok
This network shows the impact of papers produced by Anna Helbok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Helbok. The network helps show where Anna Helbok may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Helbok, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 120 | |
| 2 | 2012 | 109 | |
| 3 | 2011 | 85 | |
| 4 | 2011 | 70 | |
| 5 | 2009 | 63 | |
| 6 | 2009 | 40 | |
| 7 | 2013 | 40 | |
| 8 | 2013 | 33 | |
| 9 | 2011 | 30 | |
| 10 | 2010 | 19 | |
| 11 | 2010 | 17 | |
| 12 | 2019 | 10 | |
| 13 | 2020 | 6 | |
| 14 | 2009 | 5 | |
| 15 | Design and evaluation of novel radiolabelled VIP derivatives for tumour targeting. | 2013 | 3 |
| 16 | 2010 | 3 | |
| 17 | Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles | 2012 | 2 |
About Anna Helbok
Anna Helbok is a scholar working on Biomaterials, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Oncology and Epidemiology, having authored 17 papers that have together received 655 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Peptidase Inhibition and Analysis (3 papers), RNA Interference and Gene Delivery (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Lanthanide and Transition Metal Complexes (2 papers), Medical Imaging Techniques and Applications (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (206 citations), Biomaterials (99 citations), Infectious Diseases (111 citations), Molecular Medicine (29 citations) and Epidemiology (161 citations). Anna Helbok has collaborated with scholars based in Austria, Türkiye and United Kingdom. Frequent co-authors include Clemens Decristoforo, Miloš Petřík, Hubertus Haas, Michael Blatzer, Markus Schrettl, Cornelia Lass‐Flörl, Elisabeth von Guggenberg, Christine Rangger, Georg Dobrozemsky and Ruth Prassl. Their work appears in journals such as Nuclear Medicine and Biology, European Journal of Nuclear Medicine and Molecular Imaging, Histochemistry and Cell Biology, Nanomedicine Nanotechnology Biology and Medicine and Journal of Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.